Position in BIOA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$23,218,762
+$20,722,762 QoQ
Shares Held
1,327,545
+1006.3% QoQ
Ownership
2.99%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
2 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in BIOA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Balyasny Asset Management L.P. holds $180,059,722 across 19 Drug Manufacturers - Specialty & Generic names. BIOA ranks #3 (12.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LNTH |
Lantheus Holdings, Inc.
|
539,382 | $40,912,124 | |
| 2 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
499,792 | $24,064,984 | |
| 3 | BIOA |
BioAge Labs, Inc.
This page
|
1,327,545 | $23,218,762 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
36,623 | $21,716,706 | |
| 5 | ALKS |
Alkermes plc.
|
586,775 | $20,748,363 | |
| 6 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
1,107,271 | $15,391,066 | |
| 7 | AQST |
Aquestive Therapeutics, Inc.
|
2,900,570 | $12,037,365 | |
| 8 | PRGO |
PERRIGO Co plc
|
804,856 | $8,644,153 |
All Filings in BIOA
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $23,218,762 | 1,327,545 | Shares | Sole | 2026-05-15 | |
| 2024-09-30 | $2,496,000 | 120,000 | Shares | Sole | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||